Estimates of the Prevalence and Number of Fibromyalgia Syndrome Patients and Their Alpha-1 Antitrypsin Phenotypic Distribution in Ten Countries

REFERENCES

• Silverman G A., Bird PhI, Carrell R W., Church F C., Coughlin P B., Gettins P G., Irving J A., Lomas D A., Luke C J., Moyer R W., Pemberton P A., Remold-O'Donnell E, Salvesen G S., Travis J, Whisstock J C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001; 276(36)33293–33296
   PubMed Web of Science ®Google Scholar
• Brantly M, Nukiwa T, Crystal R G. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988; 84(6A)13–31
   PubMed Web of Science ®Google Scholar
• Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 2001; 1535(3)221–235
   PubMed Web of Science ®Google Scholar
• Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alphal-antitrypsin. Biochem Biophys Res Commun 2004; 321(3)592–600
   PubMed Web of Science ®Google Scholar
• Hadzic R, Nita I, Tassidis H, Riesbeck K, Wingren A G., Janciauskiene S. Alphal-antitrypsin in hibits Moraxella catarrhalis MID protein-induced ton-sillar B cell proliferation and IL-6 release. Immunol Lett 2006; 102(2)141–147
   PubMedGoogle Scholar
• Nita I, Hollander C, Westin U, Janciauskiene S. Prolastin, a pharmaceutical preparation of purified human alphal-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res 2005; 31(1)12–18
   Google Scholar
• Byth B C., Billingsley G D., Cox D W. Physical and genetic mapping of the serpin gene cluster at 14032.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am J Hum Genet 1994; 55(1)126–133
   PubMedGoogle Scholar
• De Serres F J. Worldwide racial and ethnic distribution of alpha-1 antitrypsin deficiency: Details of an analysis of published genetic epidemiological surveys. Chest 2002; 122(5)818–1829
   Google Scholar
• Carrell R W., Jeppsson J O., Laurell C B. Structure and variation of human alpha 1-antitrypsin. Nature 1982; 298(5872)329–334
   PubMed Web of Science ®Google Scholar
• Carrell R W., Lomas D A. Alpha-1 antitrypsin deficiency -a model for conformational diseases. N Engl J Med 2002; 346(1)45–53
   PubMed Web of Science ®Google Scholar
• Stoller J K., Snider G L., Brantly M L. American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168(7)818–855
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A., Yunus M B., Bennett R M., Bombardier C, Goldenberg D L., Tugwell P, Campbell S M., Abeles M, Clark P, Fam A G., Farber S J., Fiechtner J J., Franklin C M., Gatter R A., Hamaty D, Lessard J, Lichtbroun A S., Masi A T., McCain G A., Reynolds W J., Romano T J., Russell I J., Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Neumann L, Buskila D. Epidemiology of fibro-myalgia. Curr Pain Headache Rep 2003; 7(5)362–368
   PubMedGoogle Scholar
• Bennet R. Fibromyalgia: present to future. Curr Pain Headhache Rep 2004; 8: 379–384
   PubMedGoogle Scholar
• Staud R. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Current Rheumatol Rep 2002; 4: 299–305
   PubMedGoogle Scholar
• Blanco I, Canto H, de Serres F J., Bustillo E F., Rodríguez M C. Alpha-1-antitrypsin replacement therapy efficiently controls fibromyalgia symptoms in two PI ZZ alpha-1-antitrypsin deficiency patients. J Rheumatol 2004; 31(10)2082–2085
   PubMed Web of Science ®Google Scholar
• Blanco I, Janciauskiene S, Astudillo A, Domínguez F, Nita I, Bustillo E F. Fibromyalgia and alpha-1 antit-rypsin New Research on Fibromyalgia, J A. Pederson. Nova Publishers, New York 2006
   Google Scholar
• Blanco I, Arbesú D, Alkassam D, de Serres J, Bustillo E F., Rodríguez-Menéndez C. Alphal-antitryp-sin polymorphism in fibromyalgia patients from the Asturias Province in Northern Spain: A significantly higher prevalence of the PIZ deficiency allele in patients than in the general population. J Musculoske Pain 2006; 14(3)5–12
   Web of Science ®Google Scholar
• Blanco I E., de Serres F J., Fernández-Bustillo E, Kassam D A., Arbesu D, Rodriguez C, Torre J C. Alpha-1 antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses 2005; 64(4)759–769
   PubMed Web of Science ®Google Scholar
• MacNallyJD Matheson DA, Bakowsky V S. The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can 2006; 27(1)9–16
   PubMedGoogle Scholar
• White K P., Speechley M, Harth M, Osthye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26(7)1570–1576
   PubMed Web of Science ®Google Scholar
• White K P., Speechley M, Harth M, Osthye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999; 26(7)1577–1585
   PubMed Web of Science ®Google Scholar
• White K P., Thompson J. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 2003; 30(8)1835–1840
   PubMedGoogle Scholar
• Wolfe F, Ross K, Anderson J, Russell I J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38(1)19–28
   PubMed Web of Science ®Google Scholar
• Wolfe F, Cathey M A. Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 10(6)965–968
   PubMed Web of Science ®Google Scholar
• Prescott E, Kjoller M, Jacobsen S, Bulow P M., Danneskiold-Sansoe B, Kamper-Jorgensen F. Fibro-myalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol 1993; 22(5)233–237
   PubMed Web of Science ®Google Scholar
• Makela M., Heliovaara M. Prevalenceof primary fibromyalgia in the Finnish population. BMJ 1991; 303(6796)216–219
   PubMed Web of Science ®Google Scholar
• Raspe H. Rheumatism epidemiology in Europe. Soz Praventivmed. 1992; 37(4)168–178
   PubMedGoogle Scholar
• Schochat T, Raspe H. Elements of fibromyalgia in an open population. Rheumatology 2003; 42(7)829–835
   PubMedGoogle Scholar
• Salaffi F, De Angelis R, Grassi W. Marche Pain Prevalence, Investigation Group Mapping Study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23(6)819–828
   PubMed Web of Science ®Google Scholar
• Cimmino M A., Zampogna A, Murroni S, Barruffi S, Alessio G, Maio T, Mela G S. Methodology of an epidemiologic prevalence study in rheumatology: the Chiavari study. Reumatismo 2002; 54(1)40–47
   PubMedGoogle Scholar
• Bazelmans E., Vercoulen J H., Swanink C M., Fennis J F., Galama J M., van Weel C, van der Meer J W., Bleijenberg G. Chronic Fatigue Syndrome and Primary Fibromyalgia Syndrome as recognized by GPs. Fam Pract 1999; 16(6)602–604
   PubMedGoogle Scholar
• Picavet H SJ, Hazes J MW. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis 2003; 62(7)644–650
   PubMed Web of Science ®Google Scholar
• Gamero Ruiz F., Gabriel Sanchez R., Carbonell Abello J., Tornero Molina J., Sanchez Magro I. Pain in Spanish rheumatology outpatient offices: EPIDOR epidemiological study. Rev Clin Esp 2005; 205(4)157–163
   PubMedGoogle Scholar
• Carmona L, Ballina J, Gabriel R, Laffton A. EPISER Study Group. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Ann Rheum Dis 2001; 60(11)1040–1045
   PubMed Web of Science ®Google Scholar
• Lindell L, de Jong M P., Osikowicz W, Lazzaroni R, Gerggren M, Salaneck W R., Crispin X. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000; 18(3)149–153
   PubMed Web of Science ®Google Scholar
• Lundberg G, Gerdle B. Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol 2002; 29(3)603–613
   PubMedGoogle Scholar
• Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 1998; 37(5)491–495
   PubMedGoogle Scholar
• Haq S A., Darmawan J, Islam M N., Uddin M Z., Das B B., Rahman F, Chowdhury M A., Alam M N., Mahmud T A., Chowdhury M R., Thair M. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005; 32(2)348–353
   PubMedGoogle Scholar
• Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G. The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 2005; 34(2)140–144
   PubMed Web of Science ®Google Scholar
• Senna E R., De Barros A L., Silva E O., Costa I F., Pereira L V., Ciconelli R M., Feraz M B. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31(3)594–397
   PubMed Web of Science ®Google Scholar
• Cardiel M H., Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol 2002; 20(5)617–624
   PubMed Web of Science ®Google Scholar
• Blanco I, Fernández E, Bustillo E F. Alphal-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet 2001; 60: 31–41
   PubMed Web of Science ®Google Scholar
• Blanco I, Bustillo E F., Rodríguez M C. Distribution of al-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet 2001; 60: 431–444
   PubMed Web of Science ®Google Scholar
• De Serres F J., Blanco I, Bustillo E F. Genetic Epidemiology of Alpha-l antitrypsin Deficiency: France, Italy, Portugal and Spain. Clin Genet 2003; 63: 1–20
   PubMedGoogle Scholar
• De Serres Blanco I., Fernandez-Bustillo E. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet 2003; 64(5)382–397
   PubMed Web of Science ®Google Scholar
• Blanco I, de Serres F, Fernandez-Bustillo E, Lara B, Miravitlles M. Estimated numbers and prevalence of PIS and PIZ alleles of al-antitrypsin deficiency in European countries. Eur Respir J 2006; 27(1)77–84
   PubMed Web of Science ®Google Scholar
• Hardy-Weinberg principle. Wikipedia. Retrieved July 20. 2006, from: http://en.wikipedia.org/wiki/Hardy-Weinberg_principle
   Google Scholar
• The World Fact Book. CIA, Retrieved May, 2006 from: http://www.odci.gov/cia/publications/factbook/in-dex.html
   Google Scholar
• Cox D W., Simpsom N E., Jantti R. Group-specific component alpha-1 antitrypsin and esterase D in Canadian Eskimos. Hum Hered 1978; 28(5)341–350
   PubMedGoogle Scholar
• Singh R, Horne S L., Gerrard J W., De Coteau W E. Alpha-1 antitrypsin phenotypes in Canadian metis. Hum Hered 1983; 33: 181–183
   PubMedGoogle Scholar
• Chan-Yeung M, Ashley M J., Corey P, Maledy M. Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industries. Am Rev Respir Dis 1978; 117: 239–245
   PubMedGoogle Scholar
• Talamo R C., Thurlbeck W M. Alpha-1 antitrypsin Pi types in postmortem blood. Am rev Respir Dis 1975; 112(2)201–207
   PubMedGoogle Scholar
• Ashley J, Chan-Yeung M, Corey P N. Pi pheno-types in North American workers: racial differences and comparisons with reported frequencies. Hum Hered 1980; 30(2)107–111
   PubMedGoogle Scholar
• Moroz S P., Cutz E, Cox D W., Sass-Kortsak A. Liver disease associated with alpha-1 antitrypsin deficiency in childhood. J Pediatrics 1976; 88(1)19–25
   PubMed Web of Science ®Google Scholar
• Joly J, Richer V, Boisvert F, Laverdiere M. Al-pha-1 phenotypes in French Canadian newborns. Hum Hered 1980; 30: 1–2
   PubMedGoogle Scholar
• Horne S L., Clark M E., Barnett G D. Alpha-1-antrypsin deficiency: Its effect on pulmonary function in Saskatchewan grain buyers. Occupational Pulmonry Disease: Focus on Grain Dust and Health 1980; 347–356
   Google Scholar
• Roberts A, Kagan A, Rhoads G G. Antitrypsin and chronic obstructive pulmonary disease among Japanese-American men. Chest 1977; 72(4)489–491
   PubMedGoogle Scholar
• Cohen B H., Ball W C., Jr., Bias W B. A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations. Johns Hopkins Med J 1975; 137(3)95–104
   PubMedGoogle Scholar
• Schwartz R H., Van Ess J D., Johnstone D E. Alpha-1 antitrypsin in childhood asthma. J Allergy Clin Immunol 1977; 59(1)31–34
   PubMed Web of Science ®Google Scholar
• Rynbrandt D J., Ihrig J, Kleinerman J. Serum trypsin inhibitory capacity and Pi phenotypes. I. Methods and control values. Am J Clin Pathol 1975; 63(2)251–260
   PubMedGoogle Scholar
• Gerblich A A., Kleinerman J, Rynbrandt D J. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state. Am J Clin Pathol 1978; 69(5)509–513
   PubMedGoogle Scholar
• Dykes D D., Miller S A., Polesky H F. Distribution of alpha 1-antitrypsin variants in a US white population. Hum Hered 1984; 34(5)308–310
   PubMed Web of Science ®Google Scholar
• Morse J O., Lebowitz M D., Knudson R J. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N Engl J Med 1977; 296(21)1190–1194
   PubMed Web of Science ®Google Scholar
• Webb D R., Hyde R W., Schwartz R H. Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis 1973; 108(4)918–925
   PubMedGoogle Scholar
• Thymann M. Distribution of alpha-1-antitrypsin (Pi) phenotypes in Denmark determined by separator isoelectric focusing in agarose gel. Hum Hered 1986; 36: 19–23
   PubMed Web of Science ®Google Scholar
• Dahl M, Nordestgaard B G., Lange P, Vestbo J, Tybjaerg-Hansen A. Molecular diagnosis of intermediate and severe alpha-1 antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem 2001; 47(1)56–62
   PubMed Web of Science ®Google Scholar
• Arvilommi H. Studies on serum Pi and C3-poly-morphim in Finland. Acta Path Microbiol Scand 1972; 234(Suppl)1–50
   Google Scholar
• Fagerhol M K., Eriksson A W., Monn E. Serum Pi types in some Lappish and Finnish populations. Hum Hered 1969; 19: 360–364
   PubMedGoogle Scholar
• Arnaud P, Koistinen J, Wilson G B., Fudenberg H H. Alpha-1 antitrypsin (Pi) phenotypes in a Finish population. Scand J Clin Lab Invest 1977; 37: 339–343
   PubMed Web of Science ®Google Scholar
• Fagerhol M K., Gedde-Dahl T, Jr. Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1 antitrypsin. Hum Hered 1969; 19(4)354–359
   PubMedGoogle Scholar
• Weidinger S, Schwarzfischer F, Cleve H. Pi sub-typing by isoelectric focusing: further genetic studies and application to paternity examinations. Z Rechtsmed 1980; 86(1)1–7
   PubMedGoogle Scholar
• Weidinger S, Cleve H, Patutschnick W. Alpha-1 antitrypsin: evidence for a fourth PiM allele. Distribution of the PiM subtypes in Southern Germany. Z Rechtsmed 1982; 88(3)203–211
   PubMedGoogle Scholar
• Genz T, Martin J P., Cleve H. Classification of alphal-antitrypsin (Pi) phenotypes by isoelectrofocusing. Distinction of six subtypes of the PiM phenotype. Hum Genet 1977; 38(3)325–332
   PubMedGoogle Scholar
• Schmechta H, Geserick G. Population genetic studies on alpha-1 antitrypsin polymorphism (Pi-system) in the population of Berlin. Deutsche Gesundheitswesen-Zeitschrift Fur Klinische Medizin 1972; 27(23)1089–1091
   PubMedGoogle Scholar
• Patzelt D, Schroder H. Genetic-polymorphism of alpha-1 antitrypsin (Pi System) -Data on the formal and population-genetics of the Pi subtypes. Deutsche Gesundheitswesen-Zeitschrift Fur Klinische Medizin 1983; 38(3)119–123
   Google Scholar
• Pittschieler K, Massi G. Alpha-1 antitrypsin deficiency in two population groups in north Italy. Paedriatr Padol 1988; 23: 307–311
   PubMedGoogle Scholar
• Seefried-Lehmann S J., Walter H, Danker-Hopfe H, Ricjards O, De Stefano G F. Investigations on the variability of four genetic serum protein markers (HP; TF; CG a nd PI subtypes) in Italy. Z. Morp. Anthrop 1992; 79(2)215–231
   Google Scholar
• Massi G, Cotumaccio R, Auconi P. Alpha-1 antirypsin (Alpha-1-AT) phenotypes and PiM subtypes in Italy. Evidence of considerable geographic variability. Hum Genet 1982; 61: 76–77
   PubMedGoogle Scholar
• Piantelli M, Auconi P, Musiani P. Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. Hum Hered 1978; 28: 468–473
   PubMedGoogle Scholar
• Pascali V L., De Mercurio D L. Determination of alpha-1 antitrypsin subtypes in the population of Rome: a study in ultrathin-layer isoelectric focusing. Hum Hered 1981; 31: 296–298
   PubMedGoogle Scholar
• Massi G, Fabiano A, Ragusa D, Auconi P, Biagini R, Farinato M A., Bandelloni R. Alpha-1 anti-trypsin phenotypes and Pi M subtypes in Italy. Bull Eur Physiopathol Respir 1980; 16(Suppl.)301–306
   PubMedGoogle Scholar
• Hoffman J JML, van den Broek W GM. Distribution of alpha-1 antitrypsin phenotypes in two Dutch population groups. Hum Genet 1976; 32: 43–48
   PubMedGoogle Scholar
• Klasen E C., Biemond I, Weterman I T. Alpha-1 antitrypsin levels and phenotypes in Crohn's disease in the Netherlands. Gut 1980; 21(10)840–842
   PubMedGoogle Scholar
• Biedmond I, Shelby W S., Jewell D P. Alpha-1 antitrypsin serum concentration and phenotypes in ulcerative colitis. Digestion 1984; 29: 124–128
   PubMedGoogle Scholar
• Blanco I, Fernández E, Rodríguez M C., Fernandez A. Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias. Med Clin [Barc] 1999; 113(10)366–370
   PubMedGoogle Scholar
• Vidal R, Miravitlles M, Jardí R, Torrella M, Rodriguez-Frias F, Moral P, Vaque J. Study of the frequency of different phenotypes of alpha-1 antitrypsin in a population of Barcelona. Med Clin (Barc) 1996; 107(6)211–214
   PubMedGoogle Scholar
• Puertas M JA, Arranz-Peña M L. Alpha-1 anti-trypsin phenotypes in a newborns population from Castilla-Leon. Rev Clín Esp 1989; 184: 106–108
   PubMedGoogle Scholar
• Moral P. Estudio antropogenético de diversos polimorfismos hematológicos en la isla de Menorca Tesis Doctoral. Univ Barcelona. 1986
   Google Scholar
• Hjalmarsson K. Distribution of alpha-1 anti-typsin phenotypes in Sweden. Hum Hered 1988; 38: 27–30
   PubMedGoogle Scholar
• Shahid A, Siddiqui A A., Zuberi S J., Waqar M. Phenotypes of alpha-1 antitrypsin in Karachi, Pakistan. J Pak Med Assoc 2000; 59(11)374–376
   Google Scholar
• Wallace D J., Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman M H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumathology 2001; 40(7)743–749
   PubMed Web of Science ®Google Scholar
• Wallace D J. Is there a role for cytokine based therapies in fibromyalgia?. Curr Pharm Des 2006; 12(1)17–22
   PubMedGoogle Scholar
• Pache M, Ochs J, Genth E, Mierau R, Kube T, Flammer J. Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology 2003; 42: 493–494
   PubMed Web of Science ®Google Scholar
• Maes M, Libbrecht I, Van Hunsel F, Lin A H., De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E, Neels H. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 1999; 24(4)371–383
   PubMedGoogle Scholar
• Pay S, Calgunery M, Caliskaner Z, Dinc A, Apras S, Ertenli I, Kiraz S, Cobankara V. Evaluation of vascular injury with proinflammatory cytokines, throm-bomodulin and fibronectin in patients with primary fibromyalgia. Nagoya J Med Sci 2000; 63(3–4)115–122
   PubMedGoogle Scholar
• Gur A, Karakoc M, Nas K, Remzi Cevik, Denli A, Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29(2)358–361
   PubMedGoogle Scholar
• Gur A, Karakoc M, Erdogan S, Nas K, Cevik R, Sarac A J. Regional cerebral flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002; 20(6)753–760
   PubMedGoogle Scholar
• Hein G, Franke S. Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?. Rheumatology 2002; 41(10)1163–1167
   PubMedGoogle Scholar
• Bagis S, Tamer L, Sahin G, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int 2003; 28: 188–190
   Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2005; 10: 1–6
   Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 2005; 20: 1–13
   Google Scholar
• Salemi S, Rethage J, Wollina U, Michel B A., Gay R E., Gay S, Sprott H. Detection of Interleukin 1 beta (IL-beta), IL-6, and Tumor Necrosis Factor-alpha in Skin of Patients with Fibromyalgia. J Rheumatol 2003; 30(1)146–150
   PubMedGoogle Scholar
• Rüster M, Franke S, Späth M, Pongratz D E., Stein G, Hein G E. Detection of elevated N epsilon-carboxy-methyllysine levels in muscular tissue and in serum of patients with fibromyalgia. Scand J Rheumatol 2005; 34(6)460–463
   PubMed Web of Science ®Google Scholar
• Libert C, Van Molle W, Brouckaert P, Fiers W. Alpha-1 antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996; 157(11)5126–5129
   PubMedGoogle Scholar
• Churg A, Wang R D., Xie C, Wright J L. Alpha-1 antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003; 168(2)199–207
   PubMed Web of Science ®Google Scholar
• Knappstein S, Ide T, Schmidt M A., Heusipp G. Alpha-1 antitrypsin binds to and interferes with functionality of EspB from atypical and typical entero-pathogenic Escherichia coli strains. Infect Immun 2004; 72(8)4344–4350
   PubMedGoogle Scholar
• Aldonyte J, Jansson L, Ljungberg O, Larsson S, Janciauskiene S. Polymerized alpha-antitrypsin is present on lung vascular endothelium. New insights into the biological significance of alpha-antitrypsin polymerization. Histopathology 2004; 45(6)587–592
   PubMed Web of Science ®Google Scholar